Cefuroxime

CAS 55268-75-2 7 current records 6 historicalSmall Molecule

Who holds supplier records for Cefuroxime? 7 organisations hold a current record for Cefuroxime: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6) and Italy (1).

Most records are filed under another form of this substance: Cefuroxime Sodium (11 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cefuroxime: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefuroxime

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefuroxime. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Cefuroxime sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (6)

Organisations whose Type II DMFs for Cefuroxime are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • Qilu Antibiotics Pharmaceutical Co., Ltd.
    China · Inactive DMF 19521 · filed Jun 2006
  • ORCHID CHEMICALS AND PHARMACEUTICALS LTD
    Inactive DMF 16656 · filed Jun 2003
  • PHLOX PHARMACEUTICALS LTD
    Inactive DMF 16370 · filed Jan 2003
  • RANBAXY LABORATORIES LTD
    Inactive DMF 15670 · filed Oct 2001
  • Kyongbo Pharmaceutical Co., Ltd.
    South · Inactive DMF 15537 · filed Jun 2001
  • Italy · Inactive DMF 14010 · filed Mar 1999

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cefuroxime is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1436).

Chemical identity

IUPAC name
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Canonical SMILES
CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
InChIKey
JFPVXVDWJQMJEE-IZRZKJBUSA-N
Synonyms
640/359, Cefuroxima, Cefuroxime, Cefuroxime acid, Cefuroximine, Cephuroxime, Cefuroxim, Cefuroximo, Cefuroximum, Sharox, Zinacef Danmark, CHEBI:3515

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cefuroxime?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefuroxime: PURE AND CURE HEALTHCARE PRIVATE LTD (India), ACS DOBFAR SPA (Italy), APITORIA PHARMA PRIVATE LTD (India), COVALENT LABORATORIES PRIVATE LTD (India), Lupin Limited (India), Nectar Lifesciences Limited (India) and Orchid Pharma Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cefuroxime Drug Master Files are active?

PURE AND CURE HEALTHCARE PRIVATE LTD (DMF 21508, 23088), ACS DOBFAR SPA (DMF 10154), APITORIA PHARMA PRIVATE LTD (DMF 18453), COVALENT LABORATORIES PRIVATE LTD (DMF 21795, 24495), Lupin Limited (DMF 35617), Nectar Lifesciences Limited (DMF 22087) and Orchid Pharma Limited (DMF 17047). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cefuroxime records mean?

6 organisations have only inactive Type II DMFs for Cefuroxime. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Cefuroxime supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cefuroxime?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.